CinCor Pharma, Inc.
CINC · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|
| Market Cap | $567 | $376 | $376 |
| - Cash | $137 | $26 | $11 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $430 | $350 | $364 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$35 | -$20 | -$5 |
| % Margin | – | – | – |
| Net Income | -$50 | -$22 | -$5 |
| % Margin | – | – | – |
| EPS Diluted | -1.42 | -0.95 | -0.21 |
| % Growth | -49.5% | -352.4% | – |
| Operating Cash Flow | -$31 | -$17 | -$4 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$31 | -$17 | -$4 |